1 / 4

Validation of Alere TM q HIV-1/2 Detect for detection of acute HIV infection

Validation of Alere TM q HIV-1/2 Detect for detection of acute HIV infection at Anonymous Clinic, The Thai Red Cross AIDS Research Centre.

bergquist
Télécharger la présentation

Validation of Alere TM q HIV-1/2 Detect for detection of acute HIV infection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Validation of Alere TM q HIV-1/2 Detect for detection of acute HIV infection at Anonymous Clinic, The Thai Red Cross AIDS Research Centre IrinSrila-or1, TippawanP.1, SupanitP.1, SupphadithB.1, PanatsiriR.1, JureepornJ.1, SuphachokeA.1, SuneeS.2, PattareeyaP.1, ReshmieR.1, NittayaP.1,3, PraphanP.1,2 1. The Thai Red Cross AIDS Research Centre, Bangkok, Thailand. 2. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 3. SEARCH, Bangkok, Thailand

  2. Introduction • Diagnosis of acute HIV infection (AHI) is important for prevention and care. • Nucleic acid amplification test (NAAT) is the most sensitive test to diagnose AHI but is costly and labor intensive. • AlereTMq is a point-of-care qualitative NAAT that can detect both HIV type 1 and 2 with a detection limit of 2,500 copies/mL • Aim of the study is to evaluate the performance of Alereq in Thai AHI detection.

  3. Methods & Results Table : Alereq HIV-RNA Detectable stratified by group Alereq was run against a panel of one hundred plasma samples : • Confirmed HIV negative (10) • 4th Gen. EIA non-reactive but NAAT (APTIMA) reactive (30) • 4th Gen. reactive but 3rd Gen. non-reactive (30) • 4th Gen. and 3rd Gen. reactive but 2nd Gen. non-reactive (30) • * 8/9 Alere q negative samples had HIV-RNA below 2,500 Copies/mL, the detection limit of Alere q, the remaining one had HIV-RNA 40,311 copies/mL. • ** HIV-RNA of the only Alereq negative sample in group D was only 1,204 copies/mL. • *** Median HIV-RNA of AHI with reactive Alere q was 630,276 copies/mL which was significantly higher than those with non-reactive Alere q (282 copies/mL), p<0.001.

  4. Conclusions • Alere q is more sensitive than 4th Gen. machine base EIA but less sensitive than APTIMA. • Alere q is ideal for HIV testing in people taking PrEP especially at community roll out. • In addition to its indication for use in mother-to-child transmission, Alere q could be considered in the detection of AHI in a setting where APTIMA or HIV-RNA is not available although its sensitivity is not yet perfect.

More Related